- Home
- RGNX vs DIN Comparison
RGNX vs DIN Comparison
Compare RGNX & DIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGNX
- DIN
- Stock Information
- Founded
- RGNX 2008
- DIN 1958
- Country
- RGNX United States
- DIN United States
- Employees
- RGNX N/A
- DIN N/A
- Industry
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- DIN Restaurants
- Sector
- RGNX Health Care
- DIN Consumer Discretionary
- Exchange
- RGNX Nasdaq
- DIN Nasdaq
- Market Cap
- RGNX 451.1M
- DIN 379.1M
- IPO Year
- RGNX 2015
- DIN 1991
- Fundamental
- Price
- RGNX $9.03
- DIN $24.35
- Analyst Decision
- RGNX Strong Buy
- DIN Hold
- Analyst Count
- RGNX 8
- DIN 9
- Target Price
- RGNX $28.50
- DIN $26.57
- AVG Volume (30 Days)
- RGNX 502.6K
- DIN 513.7K
- Earning Date
- RGNX 11-05-2025
- DIN 11-05-2025
- Dividend Yield
- RGNX N/A
- DIN 8.39%
- EPS Growth
- RGNX N/A
- DIN N/A
- EPS
- RGNX N/A
- DIN 2.99
- Revenue
- RGNX $155,782,000.00
- DIN $845,368,000.00
- Revenue This Year
- RGNX $203.27
- DIN $11.28
- Revenue Next Year
- RGNX $0.58
- DIN $2.11
- P/E Ratio
- RGNX N/A
- DIN $8.14
- Revenue Growth
- RGNX 74.95
- DIN 2.92
- 52 Week Low
- RGNX $5.04
- DIN $18.63
- 52 Week High
- RGNX $13.48
- DIN $37.44
- Technical
- Relative Strength Index (RSI)
- RGNX 49.37
- DIN 59.50
- Support Level
- RGNX $8.82
- DIN $23.58
- Resistance Level
- RGNX $10.08
- DIN $24.72
- Average True Range (ATR)
- RGNX 0.54
- DIN 0.78
- MACD
- RGNX -0.05
- DIN 0.16
- Stochastic Oscillator
- RGNX 25.27
- DIN 76.36
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
About DIN Dine Brands Global Inc.
Dine Brands Global Inc owns and franchises thousands of restaurants under the Applebee's and International House of Pancakes names. Almost all company restaurants are located in the United States and franchised. Royalty revenue, which the company gets from franchisees based on franchisees' sales, accounts for roughly three-quarters of total company revenue. The company also earns revenue by leasing restaurant sites to franchisees. The company has four reportable segments Franchise operations, (an aggregation of Applebee's and IHOP franchise operations), Rental operations, Financing operations and Company-operated restaurant operations. The majority of revenue is derived from the Franchise operations segment.